Back to WELLS FARGO & COMPANY/MN WELLS FARGO & COMPANY/MN

FUSNFUSN
7 quarters

Position history for WELLS FARGO & COMPANY/MNWELLS FARGO & COMPANY/MN's holdings in FUSION PHARMACEUTICALS INC

As of its Q1 2024 13F, Wells Fargo held 1,500 shares of FUSN (Fusion Pharmaceuticals), worth $31,980. Wells Fargo's 13F filings listed FUSN from Q4 2023 to Q1 2024, 2 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$271,000

Total Shares Change

-15,517

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q1
Decreased
1,500
-70.0%
$31,9800.0%—
0
2023-Q4
New
5,000
-
$48,0500.0%—
31
2022-Q3
Exited
0
-
$00.0%—
0
2022-Q2
New
0
-
$00.0%—
17
2020-Q3
Exited
0
-100.0%
$00.0%—
0
2020-Q2
New
15,517
-
$271,0000.0%—
32

Other major holders of FUSN: FEDERATED HERMES, INC., FIL Ltd, Pentwater Capital Management LP, CANADA PENSION PLAN INVESTMENT BOARD

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used